The University of Chicago Header Logo

Connection

Kenneth S. Cohen to Adult

This is a "connection" page, showing publications Kenneth S. Cohen has written about Adult.
Connection Strength

0.261
  1. Management of pediatric and adult patients with medulloblastoma. Curr Treat Options Oncol. 2014 Dec; 15(4):581-94.
    View in: PubMed
    Score: 0.031
  2. A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood. Neuro Oncol. 2013 Jun; 15(6):783-7.
    View in: PubMed
    Score: 0.028
  3. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol. 2011 Mar; 13(3):317-23.
    View in: PubMed
    Score: 0.024
  4. Retinal thickness measurement after phacoemulsification. J Cataract Refract Surg. 2004 Jul; 30(7):1501-6.
    View in: PubMed
    Score: 0.015
  5. Familial, band-shaped, spheroidal keratopathy histopathology in ethnic Chinese siblings. Cornea. 2002 Nov; 21(8):774-7.
    View in: PubMed
    Score: 0.013
  6. Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. N Engl J Med. 2022 08 18; 387(7):599-610.
    View in: PubMed
    Score: 0.013
  7. Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age. Obstet Gynecol. 2022 09 01; 140(3):477-487.
    View in: PubMed
    Score: 0.013
  8. Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
    View in: PubMed
    Score: 0.010
  9. Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma. Neuro Oncol. 2017 Oct 19; 19(11):1542-1552.
    View in: PubMed
    Score: 0.010
  10. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study. Pediatr Blood Cancer. 2017 Nov; 64(11).
    View in: PubMed
    Score: 0.009
  11. University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL. Br J Haematol. 2018 04; 181(2):264-267.
    View in: PubMed
    Score: 0.009
  12. Use of Eculizumab in Atypical Hemolytic Uremic Syndrome, Complicating Systemic Lupus Erythematosus. J Clin Rheumatol. 2016 Sep; 22(6):320-3.
    View in: PubMed
    Score: 0.009
  13. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy. Childs Nerv Syst. 2016 Aug; 32(8):1425-30.
    View in: PubMed
    Score: 0.009
  14. Identifying early dropouts from a rehabilitation program for psychiatric outpatients. Psychiatr Serv. 1995 Oct; 46(10):1076-8.
    View in: PubMed
    Score: 0.008
  15. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol. 2012 Nov; 124(5):627-41.
    View in: PubMed
    Score: 0.007
  16. T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse. Leuk Lymphoma. 2011 Feb; 52(2):214-22.
    View in: PubMed
    Score: 0.006
  17. Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group. J Neurooncol. 2010 Sep; 99(2):155-63.
    View in: PubMed
    Score: 0.006
  18. Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol. 2010 Jun 10; 28(17):2817-23.
    View in: PubMed
    Score: 0.006
  19. Sixteen-year predictors of substance use disorder diagnoses for patients with mental health disorders. Subst Abus. 2009 Jan-Mar; 30(1):40-6.
    View in: PubMed
    Score: 0.005
  20. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Cancer. 2007 Dec 01; 110(11):2535-41.
    View in: PubMed
    Score: 0.005
  21. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood. 2008 Feb 01; 111(3):1302-5.
    View in: PubMed
    Score: 0.005
  22. Quantification of macular and optic disc hyperfluorescence after phacoemulsification in diabetes mellitus. J Cataract Refract Surg. 2006 May; 32(5):803-11.
    View in: PubMed
    Score: 0.004
  23. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol. 2004 May; 63(5):441-9.
    View in: PubMed
    Score: 0.004
  24. Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol. 2003 Mar; 25(3):198-203.
    View in: PubMed
    Score: 0.003
  25. Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol. 2002 Jan; 12(1):36-44.
    View in: PubMed
    Score: 0.003
  26. No responses to oral etoposide in 15 patients with recurrent brain tumors. Med Pediatr Oncol. 2000 Jul; 35(1):80-2.
    View in: PubMed
    Score: 0.003
  27. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant. 1998 Nov; 22(10):971-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.